{
    "paper_id": "PMC7192220",
    "metadata": {
        "title": "The long\u2010term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status",
        "authors": [
            {
                "first": "Jenny",
                "middle": [
                    "C."
                ],
                "last": "NGAI",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Fanny",
                "middle": [
                    "W."
                ],
                "last": "KO",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Susanna",
                "middle": [
                    "S."
                ],
                "last": "NG",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Kin\u2010Wang",
                "middle": [],
                "last": "TO",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mabel",
                "middle": [],
                "last": "TONG",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "David",
                "middle": [
                    "S."
                ],
                "last": "HUI",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Severe acute respiratory syndrome (SARS) is an acute severe lower respiratory illness due to infection with SARS\u2010coronavirus.\n1\n, \n2\n Between November 2002 and August 2003 there were 8096 SARS cases globally with 900 deaths.\n3\n Previous studies of survivors of acute lung injury and ARDS unrelated to SARS have shown variable degrees of residual abnormalities in pulmonary function, exercise capacity and impairment in health\u2010related quality of life.\n4\n, \n5\n, \n6\n, \n7\n, \n8\n As SARS is a disease that has recently emerged, the long\u2010term sequelae are largely unclear. Studies on the lung function outcome of SARS survivors have been reported;\n9\n, \n10\n, \n11\n, \n12\n, \n13\n, \n14\n, \n15\n, \n16\n, \n17\n, \n18\n, \n19\n however, the longest duration of follow up was around 3 years and small numbers of subjects were studied.\n18\n, \n19\n We have previously reported the 6 month\n12\n and 1 year outcomes\n13\n from the Prince of Wales Hospital SARS patient cohort, based on the available normative lung function data collected in the 1960s.\n20\n, \n21\n The objectives of the present study were to evaluate the 2\u2010year outcome of lung function, exercise capacity, health and work status of SARS survivors based on updated normative lung function data collected in Hong Kong (HK) from 2001\u20132003.\n22\n, \n23\n\n",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "All patients were followed up at the lung function laboratory at the Prince of Wales Hospital at the end of 3, 6, 12, 18 and 24 months after illness onset. Physical examination, pulmonary function testing, respiratory muscle strength measurement, 6\u2010minute walk test (6MWT) and the Medical Outcomes Study 36 item Short Form General Health Survey (SF\u201036)\n27\n were performed during each visit. The health status was compared with the HK normative data collected from a random telephone survey.\n28\n The work status of each individual was also recorded.",
            "cite_spans": [],
            "section": "Assessment ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "Lung volumes (using the nitrogen washout method), spirometry and surface area for gas exchange were performed (Vmax System; SensorMedics; Yorba Linda, CA). DLCO was determined by the single breath technique using an infrared analyser. We performed spirometry (FEV1 and FVC) according to the standards of the American Thoracic Society.\n29\n The results of spirometry, lung volume and DLCO were compared with the normative lung function data\n20\n, \n21\n (which were widely adopted as the reference data in HK before 2006) and also with the updated spirometric\n22\n and DLCO reference values.\n23\n Measurement of the maximum static inspiratory pressure (PImax) and the maximum static expiratory pressure (PEmax) were performed by a mouth pressure meter via a flanged mouthpiece.\n30\n, \n31\n The 6MWD was compared against normative reference data collected from a population survey of 538 normal healthy subjects in 2004 conducted by the Coordinating Committee in Physiotherapy, Hong Kong Hospital Authority.\n12\n, \n13\n\n",
            "cite_spans": [],
            "section": "Assessment ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "Continuous variables were compared using independent sample t\u2010test. The lung function, 6MWD and SF\u201036 of patients admitted to the Intensive Care Unit (requiring intubation or not) were compared using the non\u2010parametric Mann\u2013Whitney U\u2010test. Repeated measures analysis of variance (anova) was used to assess serial changes in lung function test, 6MWD and SF\u201036 domains. Paired sample t\u2010test was used to test the point of plateau in 6MWD. Univariate and multivariate analysis were performed to evaluate the potential determinants of 6MWD. Pearson correlation was used to test the correlations among SF\u201036, lung function and 6MWD. Statistical analysis was performed using the Statistical Package for Social Science (SPSS) Statistical software for Window, Version 13.0 (SPSS Inc, IL, USA).",
            "cite_spans": [],
            "section": "Statistical analysis ::: METHODS",
            "ref_spans": []
        },
        {
            "text": "The results of serial lung function and respiratory muscle strength testing over 24 months among SARS survivors are shown in Table 2. The percentage of SARS survivors with lung function parameters < 80% of predicted compared with the outdated\n20\n, \n21\n and the updated local reference values\n22\n, \n23\n and the percentages of survivors with PImax and PEmax < 80 cm H2O at 24 months are shown in Table 3.",
            "cite_spans": [],
            "section": "Lung function tests and respiratory muscle strength ::: RESULTS",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 132,
                    "mention": "Table 2",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 394,
                    "end": 401,
                    "mention": "Table 3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "According to the American Thoracic Society criteria of severity of DLCO impairment, 20 (36.4%), 7 (12.7%) and 2 (3.6%) patients had mild, moderate and severe impairment, respectively, based on the updated reference values.\n23\n Two patients (3.6%) had obstructive spirometric abnormality; one of these had a history of COPD and pneumoconiosis and the other had a significant smoking history (25 pack\u2010years). Three patients (5.5%) had restrictive abnormality without any comorbidity that would account for the abnormal lung function result.",
            "cite_spans": [],
            "section": "Lung function tests and respiratory muscle strength ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "The mean (SD) 6MWD increased significantly from 439.0 (89.1) m at 3 months to 460.1 (102.8) m at 6 months (P\u2010value = 0.016) and then became steady. The mean (SD) 6MWD at 12 months, 18 months and 24 months were 464.7 (101.9) m, 466.3 (91) m and 462.6 (120) m, respectively. The P\u2010value for trend from 3 months to 24 months was 0.45.",
            "cite_spans": [],
            "section": "6\u2010minute walk test ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "The SARS survivors\u2019 exercise capacity was generally lower than that of normal subjects (Table 4). None had significant hypoxia after the 6MWT. There were no significant associations between 6MWD and any of the following: BMI, total steroid dose, length of hospital stay, admission to ICU, baseline LDH, peak LDH, baseline CRP, peak CRP, FEV1%, FVC%, DLCO%, gas transfer corrected for alveolar volume (KCO%) at 24 months post SARS.",
            "cite_spans": [],
            "section": "6\u2010minute walk test ::: RESULTS",
            "ref_spans": [
                {
                    "start": 88,
                    "end": 95,
                    "mention": "Table 4",
                    "ref_id": "TABREF3"
                }
            ]
        },
        {
            "text": "There was impairment in all SF\u201036 domains (P < 0.01) at 24 months, except for role limitation due to emotional problems and mental heath for the age group 18\u201340 years (Fig. 1). Significant worsening of bodily pain was observed: 65.8 (SD, 4.01), 59.4 (SD, 3.8), 60.5 (SD, 3.7), 54.4 (SD, 3.6) and 53.8 (SD, 3.5) at 3, 6, 12, 18 and 24 months, respectively (P 0.025). The only two significant positive correlations between lung function indices and SF\u201036 domains were between FVC (r = 0.363, P < 0.01) and FEV1 (r = 0.3, P < 0.05) with physical functioning. However, 6MWD had significant positive correlations with all SF 36 domains except for emotional problems and mental heath.",
            "cite_spans": [],
            "section": "Health\u2010related quality of life among severe acute respiratory syndrome survivors ::: RESULTS",
            "ref_spans": [
                {
                    "start": 168,
                    "end": 174,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "The lung function results at 24 months showed significantly lower mean (SD) TLC% (88.3(14.7) vs. 100.7 (12.8)%; 95% CI 3.7\u201321.1, P = 0.006) and VC% (87.8 (15.5) vs. 97.3(12.6); 95% CI 0.75\u201318.2%, P = 0.034) in survivors who had required ICU support compared with those treated on the medical wards. However, there was no significant difference in 6MWD and SF\u201036 assessment between two groups. The ICU patients were further stratified into intubated (n = 4) and non\u2010intubated groups (n = 8). The intubated group had a significantly lower median (interquartile range) DLCO% (56.5 (3.3) vs. 82 (25.8); P = 0.042) and a lower KCO% (93.5(16.3) vs. 126.5 (22.3); P = 0.007). There was no significant difference in 6MWD and SF\u201036 domain scores between two groups at 24 months.",
            "cite_spans": [],
            "section": "Comparisons of patients who required ICU support versus those who were treated on the medical wards ::: RESULTS",
            "ref_spans": []
        },
        {
            "text": "The percentages of patients who had returned to work over 24 months are shown in Table 5. At 2 years, up to 29.6% of HCW but only 7.1% of non\u2010HCW had not returned to work.",
            "cite_spans": [],
            "section": "Work status ::: RESULTS",
            "ref_spans": [
                {
                    "start": 81,
                    "end": 88,
                    "mention": "Table 5",
                    "ref_id": "TABREF4"
                }
            ]
        },
        {
            "text": "This prospective cohort study has shown that 52% of SARS survivors had persistent impairment in DLCO and that exercise capacity and health status were significantly lower than the normal controls of the same age groups at 24 months post\u2010illness. In addition, only 78% of SARS survivors had returned to work and 29% of the HCW had not resumed duty.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "With more than one half of the patients having abnormal DLCO at 24 months, the data suggest impairment in the intra\u2010alveolar diffusion pathway. Su et al.\n\n18\n reported 8/13 (61.5%) patients in Taiwan and Liu et al.\n\n19\n reported 5.4% of 39 patients in Beijing who had impairment in DLCO at 14 months and 36 months, respectively. However, these two studies were limited by very small sample sizes of highly selected patients.\n18\n, \n19\n The static trend of DLCO impairment over 24 months in the current study was different from other long\u2010term follow\u2010up studies that showed improvement in DLCO over 1 year in Singapore,\n16\n and in Beijing.\n17\n, \n19\n This might be explained by different methodologies in measuring DLCO among the studies. Studies of ARDS survivors unrelated to SARS have shown significant restrictive and obstructive impairment in pulmonary function tests.\n32\n, \n33\n, \n34\n Up to 76% of ARDS survivors at 5 years after recovery had impairment in DLCO.\n34\n It is difficult to interpret the clinical significance of the trend of KCO found, as the alveolar volume effect has not been validated in lung diseases in which lung pathology has reduced carbon monoxide (CO) uptake properties as well as alveolar volume.\n35\n, \n36\n\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "All the spirometric and lung volume parameters remained static during the study period except for a decreasing trend in the mean of the forced expiratory flow (FEF)%25\u201375. The percentages of patients with spirometry and lung volume impairment and restrictive abnormality at 24 months were similar to the previous 3\u201312 month follow\u2010up studies on SARS survivors.\n9\n, \n11\n, \n15\n The overall pattern of lung function impairment in our study suggests small airway disease and impairment in the diffusion pathway in the SARS survivors. There were 33% and 27.8% of SARS survivors who had abnormal total CXR scores at 6 months and 12 months, respectively, in our cohort.\n12\n, \n13\n The lung function impairment findings are consistent with the CT images of SARS survivors showing persistent ground glass opacity, reticular opacities and traction bronchiectasis suggesting fibrosis.\n37\n, \n38\n, \n39\n Despite the absence of bronchiolitis in the imaging of SARS patients during the acute phase, air trapping was often present and persisted in the CT scanning of SARS survivors 6 months post\u2010infection. These findings probably reflected damage to the ciliated respiratory epithelia during the acute disease but were radiologically occult in most patients.\n39\n Our findings are also consistent with the histological features of SARS cases. The predominant pathological finding in SARS was diffuse alveolar damage in the early phase of the disease\n24\n but in the later course of disease, dense septal and alveolar fibrosis were seen.\n40\n A direct correlation was found between the extent of fibrosis and the duration of the illness.\n41\n, \n42\n The restrictive abnormality of lung function might have also been partially due to respiratory muscle weakness, as demonstrated by persistent abnormal PEmax and decreasing trend of PImax over 24 months.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "The discrepancies of the percentages of SARS survivors with abnormal lung function based on different reference values may have significant implications on compensation decisions, with more SARS patients having abnormal lung function parameters using the updated reference data\n22\n, \n23\n than the outdated values,\n20\n, \n21\n which were used by the local health authority for judging the extent of impairment.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Previous studies on SARS survivors have reported persistent impairment in exercise capacity up to 14 months post\u2010illness.\n12\n, \n13\n, \n15\n, \n18\n This observation was similar to that of survivors of ARDS unrelated to SARS.\n4\n, \n33\n The decrease in exercise capacity has been attributed to several factors. Diffusion impairment and respiratory muscle weakness might result in exertional dyspnoea and limit performance of 6MWT. However, the reduced exercise capacity after hospital discharge in SARS survivors could not be accounted for by impairment of pulmonary function alone,\n12\n, \n13\n, \n18\n, \n19\n whereas extra\u2010pulmonary causes such as physical deconditioning, muscle weakness and poor motivation were contributing factors. Several reasons for muscle weakness were suggested, including viral\u2010induced myositis at initial presentation, muscle wasting and deconditioning due to prolonged bed rest, steroid myopathy and critical illness\u2010associated poly\u2010neuropathy or myopathy.\n12\n, \n13\n, \n18\n, \n19\n, \n43\n\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "The persistent impairment of 6MWD was an important contributor to the reduced quality of life over 24 months. In addition to the physical impairment, mental impairment is expected as the major SARS outbreak in 2003 was a traumatic experience for the SARS survivors.\n44\n A striking finding was that 10 patients in our cohort had suffered from depression or post\u2010traumatic stress disorder requiring psychiatric support. This finding was echoed by the observation that 10\u201318% of SARS survivors in HK had symptoms related to post\u2010traumatic stress disorder, anxiety and depression.\n44\n Among SARS survivors in Canada, psychiatrist consultations accounted for the greatest numbers of health\u2010care visits.\n15\n Similarly impaired health status was reported in ARDS survivors unrelated to SARS.\n4\n, \n8\n, \n33\n, \n34\n\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "It was reported that 66% of SARS patients in Canada had returned to full\u2010time work 1 year after SARS.\n15\n Our study had higher percentages of patients returning to work at 1 and 2 years. Studies on ARDS unrelated to SARS have reported that 49% and 65% of ARDS survivors returned to full\u2010time work at 1 year and 2 years, respectively.\n4\n, \n33\n In our study, the lower percentage of HCW returning to work compared with non\u2010HCW may be explained by the profound psychological trauma of the SARS outbreak at our hospital that involved a high percentage of HCW.\n24\n HCW with SARS had significantly higher stress levels, higher depression, anxiety and post\u2010traumatic symptoms 1 year after the outbreak than non\u2010health\u2010care SARS survivors.\n45\n\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "There are several limitations to this study. First, although this study had the largest sample size for a 2\u2010year follow\u2010up study, only 55 of the 123 (39.9%) survivors in the early cohort\n24\n completed serial assessments over 24 months. The high default rate was likely to be related to patients\u2019 efforts to reduce the SARS\u2010associated stigma.\n46\n Those who had returned for follow up had more severe disease at onset and lower lung function parameters at 3 months. The results might therefore not be representative of the entire cohort. Second, 27% of SARS survivors in our cohort had medical comorbidities. This might have introduced additional impairment of exercise capacity and health status. Third, cardiopulmonary exercise testing was not performed in this study as most patients complained of generalized muscle weakness on initial follow up.\n12\n, \n13\n As a result, the extra\u2010pulmonary factors contributing to the 6MWT could not be measured. Finally, respiratory muscle strength was assessed by mouth pressure in our study. Low PEmax or PImax values might be due to poor motivation and technical difficulties such as mouth leakage.\n30\n\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "In summary, 2 years after SARS onset, more than 50% of this highly selected group of SARS survivors had impairment in DLCO. Their exercise capacity and health status were remarkably lower than that of the general population and 30% of HCW had not returned to work. SARS can lead to persistent mental and physical abnormalities in survivors, with a greater adverse impact on HCW. Health authorities should provide good support and follow up for these patients including HCW.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Comparison of the characteristics and lung function of non\u2010defaulters and defaulters at 3 months after disease onset\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Results of serial pulmonary function tests and respiratory muscle strength (% of predicted) among SARS survivors (n = 55)\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Percentage of SARS survivors with lung function parameters < 80% of predicted of the old and the updated local reference values, and the percentage of survivors with PImax and PEmax less than 80 cm H2O at 24 months\n",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table 4: 6MWD among SARS survivors (n = 48)\n\u2020\n at 24 months after illness onset in comparisons with Hong Kong normative data\n\u2021\n\n\n",
            "type": "table"
        },
        "TABREF4": {
            "text": "Table 5: The number and percentage of SARS survivors (n = 55) who had returned to work within 24 months\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: Health status (Short Form General Health Survey\u2014SF\u201036) among survivors of severe acute respiratory syndrome at 3, 6, 12, 18 and 24 months after illness onset in comparisons with Hong Kong normative data stratified into different age groups. The vertical axis represents the SF\u201036 domain score in mean (SD) ranging from 0 (minimum) to 100 (maximum), whereas the horizontal axis defines age groups in years. BP, bodily pain; GH, general health; MH, mental health; PF, physical functioning; RE, emotional problem; RP, physical problems; SF, social functioning; VT, vitality. *Significant at P < 0.01; **Significant at P < 0.03; #Significant at P < 0.01.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Identification of a novel coronavirus in patients with severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "N. Engl. J. Med.",
            "volume": "348",
            "issn": "",
            "pages": "1967-76",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Follow\u2010up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge",
            "authors": [],
            "year": 2005,
            "venue": "Chest",
            "volume": "127",
            "issn": "",
            "pages": "2119-24",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors",
            "authors": [],
            "year": 2004,
            "venue": "Thorax",
            "volume": "59",
            "issn": "",
            "pages": "889-91",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "The impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors",
            "authors": [],
            "year": 2005,
            "venue": "Thorax",
            "volume": "60",
            "issn": "",
            "pages": "401-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "The 1\u2010year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors",
            "authors": [],
            "year": 2005,
            "venue": "Chest",
            "volume": "128",
            "issn": "",
            "pages": "2247-61",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Dynamic changes of serum SARS\u2010coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge",
            "authors": [],
            "year": 2005,
            "venue": "Respir. Res.",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "One year outcomes and health care utilization in survivors of severe acute respiratory syndrome",
            "authors": [],
            "year": 2007,
            "venue": "Arch. Intern. Med.",
            "volume": "167",
            "issn": "",
            "pages": "1312-20",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "1\u2010year pulmonary function and health status in survivors of severe acute respiratory syndrome",
            "authors": [],
            "year": 2005,
            "venue": "Chest",
            "volume": "128",
            "issn": "",
            "pages": "1393-400",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "A follow\u2010up study of the lung function and the chest CT changes in medical staff with severe acute respiratory syndrome in Beijing",
            "authors": [],
            "year": 2005,
            "venue": "Zhonghua Jie He He Hu Xi Za Zhi",
            "volume": "28",
            "issn": "",
            "pages": "10-12",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Exercise capacity and pulmonary function in hospital workers recovered from severe acute respiratory syndrome",
            "authors": [],
            "year": 2007,
            "venue": "Respiration",
            "volume": "74",
            "issn": "",
            "pages": "511-16",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Changes in pulmonary function in SARS patients during the three\u2010year convalescent period",
            "authors": [],
            "year": 2007,
            "venue": "Zhongguo Wei Zhong Bing Ji Jiu Yi Xue",
            "volume": "19",
            "issn": "",
            "pages": "536-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Aetiology: ss's postulates fulfilled for SARS virus",
            "authors": [],
            "year": 2003,
            "venue": "Nature",
            "volume": "423",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "A major outbreak of severe acute respiratory syndrome in Hong Kong",
            "authors": [],
            "year": 2003,
            "venue": "N. Engl. J. Med.",
            "volume": "348",
            "issn": "",
            "pages": "1986-94",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Severe acute respiratory syndrome (SARS) updated interim U.S. case definition",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak",
            "authors": [],
            "year": 2004,
            "venue": "Thorax",
            "volume": "59",
            "issn": "",
            "pages": "414-20",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF 36 health survey",
            "authors": [],
            "year": 1998,
            "venue": "J. Clin. Epidemiol.",
            "volume": "51",
            "issn": "",
            "pages": "1139-47",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Population based norming of the Chinese (HK) version of the SF 36 health survey",
            "authors": [],
            "year": 1999,
            "venue": "Hong Kong Pract.",
            "volume": "21",
            "issn": "",
            "pages": "460-70",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Standardization of spirometry, 1994 update",
            "authors": [],
            "year": 1995,
            "venue": "Am. J. Respir. Crit. Care Med.",
            "volume": "152",
            "issn": "",
            "pages": "1107-36",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Pulmonary function studies in healthy Chinese adults in Singapore",
            "authors": [],
            "year": 1971,
            "venue": "Am. Rev. Respir. Dis.",
            "volume": "104",
            "issn": "",
            "pages": "128-31",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Clinical usefulness of the single\u2010breath pulmonary diffusing capacity test",
            "authors": [],
            "year": 1961,
            "venue": "Am. Rev. Respir. Dis.",
            "volume": "84",
            "issn": "",
            "pages": "789-806",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization",
            "authors": [],
            "year": 2006,
            "venue": "Chest",
            "volume": "129",
            "issn": "",
            "pages": "384-92",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Reference values of diffusing capacity of non\u2010smoking Chinese in Hong Kong",
            "authors": [],
            "year": 2007,
            "venue": "Respirology",
            "volume": "12",
            "issn": "",
            "pages": "599-606",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July, 2003",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Statement on respiratory muscle testing",
            "authors": [],
            "year": 2002,
            "venue": "Am. J. Respir. Crit. Care Med.",
            "volume": "166",
            "issn": "",
            "pages": "518-624",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Comparison of two different mouthpieces for the measurement of Pimax and Pemax in normal and weak subjects",
            "authors": [],
            "year": 1988,
            "venue": "Eur. Respir. J.",
            "volume": "9",
            "issn": "",
            "pages": "863-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Long\u2010term assessment of lung function in survivors of severe ARDS",
            "authors": [],
            "year": 2003,
            "venue": "Chest",
            "volume": "123",
            "issn": "",
            "pages": "845-53",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Two year outcomes, health care use, and costs of survivors of Acute Respiratory Distress Syndrome",
            "authors": [],
            "year": 2006,
            "venue": "Am. J. Respir. Crit. Care Med.",
            "volume": "174",
            "issn": "",
            "pages": "538-44",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Pulmonary function and health\u2010related quality of life in a sample of long\u2010term survivors of the acute respiratory distress syndrome",
            "authors": [],
            "year": 2000,
            "venue": "Intensive Care Med.",
            "volume": "26",
            "issn": "",
            "pages": "1304-11",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "In defense of the carbon monoxide transfer coefficient KCO (TL/VA)",
            "authors": [],
            "year": 2001,
            "venue": "Eur. Respir. J.",
            "volume": "17",
            "issn": "",
            "pages": "168-74",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Standardisation of the single\u2010breath determination of carbon monoxide uptake in the lung",
            "authors": [],
            "year": 2005,
            "venue": "Eur. Respir. J.",
            "volume": "26",
            "issn": "",
            "pages": "720-35",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin\u2010section CT",
            "authors": [],
            "year": 2005,
            "venue": "Radiology",
            "volume": "236",
            "issn": "",
            "pages": "1067-75",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Severe acute respiratory syndrome thin\u2010section computed tomography features, temporal changes and clinical radiological correlation during the convalescent period",
            "authors": [],
            "year": 2004,
            "venue": "J. Comput. Assist. Tomogr.",
            "volume": "28",
            "issn": "",
            "pages": "790-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic\u2010radiologic correlates of an emerging disease",
            "authors": [],
            "year": 2006,
            "venue": "J. Thoracic Imaging",
            "volume": "21",
            "issn": "",
            "pages": "276-83",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "One\u2010year outcomes in survivors of the acute respiratory distress syndrome",
            "authors": [],
            "year": 2003,
            "venue": "N. Engl. J. Med.",
            "volume": "348",
            "issn": "",
            "pages": "683-93",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Evolution of pulmonary pathology in severe acute respiratory syndrome",
            "authors": [],
            "year": 2005,
            "venue": "J. Formos. Med. Assoc.",
            "volume": "104",
            "issn": "",
            "pages": "75-81",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)",
            "authors": [],
            "year": 2004,
            "venue": "J. Clin. Pathol.",
            "volume": "57",
            "issn": "",
            "pages": "260-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Pulmonary pathology of severe acute respiratory syndrome in Toronto",
            "authors": [],
            "year": 2005,
            "venue": "Mod. Pathol.",
            "volume": "18",
            "issn": "",
            "pages": "1-10",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Neuromuscular disorders in severe acute respiratory syndrome",
            "authors": [],
            "year": 2004,
            "venue": "Arch. Neurol.",
            "volume": "61",
            "issn": "",
            "pages": "1669-73",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS)",
            "authors": [],
            "year": 2005,
            "venue": "J. Trauma. Stress",
            "volume": "18",
            "issn": "",
            "pages": "39-42",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Stress and psychological distress among SARS survivors 1\u2003year after the outbreak",
            "authors": [],
            "year": 2007,
            "venue": "Can. J. Psychiatry",
            "volume": "52",
            "issn": "",
            "pages": "233-40",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "The SARS\u2010associated stigma of SARS victims in the post\u2010SARS era of Hong Kong",
            "authors": [],
            "year": 2008,
            "venue": "Qual. Health Res.",
            "volume": "18",
            "issn": "",
            "pages": "729-38",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Long\u2010term follow\u2010up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome",
            "authors": [],
            "year": 1978,
            "venue": "Am. Rev. Respir. Dis.",
            "volume": "117",
            "issn": "",
            "pages": "449-54",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Pulmonary function following the adult respiratory distress syndrome",
            "authors": [],
            "year": 1978,
            "venue": "Chest",
            "volume": "74",
            "issn": "",
            "pages": "489-90",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome",
            "authors": [],
            "year": 1989,
            "venue": "Am. Rev. Respir. Dis.",
            "volume": "139",
            "issn": "",
            "pages": "1163-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Pulmonary function and health\u2010related quality of life in survivors of acute respiratory distress syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Am. J. Respir. Crit. Care Med.",
            "volume": "167",
            "issn": "",
            "pages": "690-4",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome",
            "authors": [],
            "year": 2004,
            "venue": "Eur. Respir. J.",
            "volume": "24",
            "issn": "",
            "pages": "436-42",
            "other_ids": {
                "DOI": []
            }
        }
    }
}